Mylan CEO to testify in hearing on EpiPen price increases
WASHINGTON (AP) – The head of Mylan will face lawmakers’ questions at a hearing next week on steep price hikes for the company’s life-saving EpiPen injector device. Mylan CEO Heather Bresch and officials from the Food and Drug Administration will testify before the House Oversight and Government Reform Committee. The Republican chairman of the committee…